Clinical experience of using clofazimine to treat multidrug-resistant tuberculosis [Correspondence].
Jung-Wan
JW
Yoo
Jiwon
J
Lyu
Sang Do
SD
Lee
Woo Sung
WS
Kim
Dong Soon
DS
Kim
Tae Sun
TS
Shim
D000081:Acetamides / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002991:Clofazimine / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000069349:Linezolid; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D023303:Oxazolidinones / Q000627:therapeutic use; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D055815:Young Adult
D000081:Acetamides; D000995:Antitubercular Agents; D023303:Oxazolidinones; D002991:Clofazimine; D000069349:Linezolid